Departments of Ophthalmology.
Neurology, Mayo Clinic, Rochester, MN.
J Glaucoma. 2021 Mar 1;30(3):227-234. doi: 10.1097/IJG.0000000000001774.
In this population-based study of 509 open-angle glaucoma (OAG) patients over a 36-year period, we identified a decreased rate of developing dementia compared with the rate in the general population.
The aim was to determine the incidence of dementia and Alzheimer disease (AD) among patients with OAG.
Retrospective, population-based cohort study. All residents of Olmsted County, Minnesota (≥40 y) who were diagnosed with OAG between January 1, 1965 and December 31, 2000, were eligible for inclusion in this study. A total of 509 patients were included over the 36-year period. The cumulative probability of developing dementia was calculated and compared with the population risk of dementia.
Of the 509 patients included, 300 (58.9%) were female, the median age was 67.5 years, and 278 patients (54.6%) had primary OAG. Other subgroups were pseudoexfoliation in 15.1%, treated ocular hypertension in 14.1%, normal tension glaucoma in 10.6%, and pigmentary glaucoma in 5.5% of the patients. Respectively, 118 (23.0%) and 99 (19.4%) patients developed dementia and AD. The 10-year cumulative probability of developing dementia and AD was 12.0% and 9.9%, with a 95% confidence interval of 9.3%-15.3% and 7.5%-13%, respectively. The observed 10-year incidence of dementia and AD were significantly lower than the expected population incidence (19.0% and 19.0%; P<0.001). Older age at diagnosis of glaucoma was a strong predictor for the development of dementia by multivariate analysis (hazard ratio: 3.31, 95% confidence interval: 2.61-4.20, P<0.001).
The risk of developing dementia or AD was decreased in OAG patients compared with the general population. OAG with onset at a later age may present as a different etiopathogenetic entity compared with onset at a younger age, and represent the optic nerve findings of generalized neurodegenerative processes.
本研究对 509 名在 36 年内患有开角型青光眼(OAG)的患者进行了一项基于人群的研究,发现与普通人群相比,这些患者发展为痴呆的比率有所下降。
旨在确定 OAG 患者发生痴呆和阿尔茨海默病(AD)的几率。
回顾性人群队列研究。所有明尼苏达州奥姆斯特德县(≥40 岁)在 1965 年 1 月 1 日至 2000 年 12 月 31 日期间被诊断为 OAG 的居民都有资格参加本研究。在 36 年的时间里,共有 509 名患者被纳入研究。计算并比较了发展为痴呆的累积概率和人群中痴呆的风险。
509 名患者中,300 名(58.9%)为女性,中位年龄为 67.5 岁,278 名(54.6%)患者为原发性 OAG。其他亚组为假性剥脱综合征 15.1%,治疗性高眼压 14.1%,正常眼压性青光眼 10.6%,色素性青光眼 5.5%。分别有 118 名(23.0%)和 99 名(19.4%)患者发展为痴呆和 AD。痴呆和 AD 的 10 年累积概率分别为 12.0%和 9.9%,置信区间分别为 9.3%-15.3%和 7.5%-13%。观察到的痴呆和 AD 10 年发病率明显低于预期的人群发病率(19.0%和 19.0%;P<0.001)。多变量分析显示,青光眼诊断时年龄较大是发生痴呆的一个强有力的预测因素(风险比:3.31,95%置信区间:2.61-4.20,P<0.001)。
与普通人群相比,OAG 患者发生痴呆或 AD 的风险降低。发病年龄较大的 OAG 可能与发病年龄较小的 OAG 存在不同的病因发病机制,代表了广泛性神经退行性过程的视神经表现。